**Core Concept:** Tuberculosis is an infectious disease caused by the bacteria Mycobacterium tuberculosis, which primarily affects the lungs (pulmonary tuberculosis). Treatment options depend on the stage of pregnancy and the severity of the disease.

**Why the Correct Answer is Right:** In the first trimester of pregnancy, the recommended treatment for sputum positive pulmonary tuberculosis is a combination of antibiotics. The standard first-line treatment regimen includes isoniazid, rifampicin, pyrazinamide, and ethambutol. This regimen is effective against both the mother and the fetus, as it targets the bacteria directly. This combination ensures a higher success rate and a decreased risk of drug resistance.

**Why Each Wrong Option is Incorrect:**

A. Isoniazid monotherapy is not effective in treating sputum positive pulmonary tuberculosis due to its poor bactericidal activity and low penetration into the central nervous system, which is a concern in pregnant patients.

B. Rifampicin monotherapy is ineffective because it has a low bactericidal effect and poor penetration into the central nervous system.

C. Pyrazinamide monotherapy is not the best choice because it has moderate bactericidal activity, poor penetration into the central nervous system, and is associated with a higher risk of bone marrow suppression.

D. Ethambutol monotherapy is not a suitable treatment option due to its limited bactericidal activity and poor central nervous system penetration, which increases the risk of optic neuritis.

**Clinical Pearl:** The correct treatment regimen ensures adequate drug penetration into the central nervous system to target the bacteria in the mother and the developing fetus. In addition to this, it minimizes the risk of drug resistance and side effects. Monitoring maternal and fetal outcomes during treatment is crucial to ensure a successful outcome for both the mother and the developing fetus.